97 related articles for article (PubMed ID: 19307009)
1. The high-risk HPV E6 oncoprotein preferentially targets phosphorylated nuclear forms of hDlg.
Narayan N; Subbaiah VK; Banks L
Virology; 2009 Apr; 387(1):1-4. PubMed ID: 19307009
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of the discs large tumour suppressor protein controls its membrane localisation and enhances its susceptibility to HPV E6-induced degradation.
Massimi P; Narayan N; Cuenda A; Banks L
Oncogene; 2006 Jul; 25(31):4276-85. PubMed ID: 16532034
[TBL] [Abstract][Full Text] [Related]
3. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.
Thatte J; Banks L
J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500
[TBL] [Abstract][Full Text] [Related]
4. Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes.
Watson RA; Thomas M; Banks L; Roberts S
J Cell Sci; 2003 Dec; 116(Pt 24):4925-34. PubMed ID: 14625386
[TBL] [Abstract][Full Text] [Related]
5. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6.
Lichtig H; Algrisi M; Botzer LE; Abadi T; Verbitzky Y; Jackman A; Tommasino M; Zehbe I; Sherman L
Virology; 2006 Jun; 350(1):216-27. PubMed ID: 16519914
[TBL] [Abstract][Full Text] [Related]
6. High-risk HPV E6 oncoproteins assemble into large oligomers that allow localization of endogenous species in prototypic HPV-transformed cell lines.
García-Alai MM; Dantur KI; Smal C; Pietrasanta L; de Prat-Gay G
Biochemistry; 2007 Jan; 46(2):341-9. PubMed ID: 17209544
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 18 E6 protein binds the cellular PDZ protein TIP-2/GIPC, which is involved in transforming growth factor beta signaling and triggers its degradation by the proteasome.
Favre-Bonvin A; Reynaud C; Kretz-Remy C; Jalinot P
J Virol; 2005 Apr; 79(7):4229-37. PubMed ID: 15767424
[TBL] [Abstract][Full Text] [Related]
8. HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation.
Massimi P; Gammoh N; Thomas M; Banks L
Oncogene; 2004 Oct; 23(49):8033-9. PubMed ID: 15378012
[TBL] [Abstract][Full Text] [Related]
9. HPV16 E6 Controls the Gap Junction Protein Cx43 in Cervical Tumour Cells.
Sun P; Dong L; MacDonald AI; Akbari S; Edward M; Hodgins MB; Johnstone SR; Graham SV
Viruses; 2015 Oct; 7(10):5243-56. PubMed ID: 26445057
[TBL] [Abstract][Full Text] [Related]
10. Association of cottontail rabbit papillomavirus E6 oncoproteins with the hDlg/SAP97 tumor suppressor.
Du M; Fan X; Hanada T; Gao H; Lutchman M; Brandsma JL; Chishti AH; Chen JJ
J Cell Biochem; 2005 Apr; 94(5):1038-45. PubMed ID: 15669058
[TBL] [Abstract][Full Text] [Related]
11. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
12. HPV-16E6 can induce multiple site phosphorylation of p53.
Zhang G; Sun L; Li Z; Si L; Song T; Huang C; Zhang W
Oncol Rep; 2009 Feb; 21(2):371-7. PubMed ID: 19148510
[TBL] [Abstract][Full Text] [Related]
13. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
[TBL] [Abstract][Full Text] [Related]
14. E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway.
Contreras-Paredes A; De la Cruz-Hernández E; Martínez-Ramírez I; Dueñas-González A; Lizano M
Virology; 2009 Jan; 383(1):78-85. PubMed ID: 19007961
[TBL] [Abstract][Full Text] [Related]
15. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein.
Zhang Y; Dasgupta J; Ma RZ; Banks L; Thomas M; Chen XS
J Virol; 2007 Apr; 81(7):3618-26. PubMed ID: 17267502
[TBL] [Abstract][Full Text] [Related]
16. A systematic analysis of human papillomavirus (HPV) E6 PDZ substrates identifies MAGI-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions.
Kranjec C; Banks L
J Virol; 2011 Feb; 85(4):1757-64. PubMed ID: 21123374
[TBL] [Abstract][Full Text] [Related]
17. HPV E6 proteins interact with specific PML isoforms and allow distinctions to be made between different POD structures.
Guccione E; Lethbridge KJ; Killick N; Leppard KN; Banks L
Oncogene; 2004 Jun; 23(27):4662-72. PubMed ID: 15107834
[TBL] [Abstract][Full Text] [Related]
18. Solution structure of the hDlg/SAP97 PDZ2 domain and its mechanism of interaction with HPV-18 papillomavirus E6 protein.
Liu Y; Henry GD; Hegde RS; Baleja JD
Biochemistry; 2007 Sep; 46(38):10864-74. PubMed ID: 17713926
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of human papillomavirus E6 by protein kinase A: conditional degradation of human discs large protein by oncogenic E6.
Kühne C; Gardiol D; Guarnaccia C; Amenitsch H; Banks L
Oncogene; 2000 Nov; 19(51):5884-91. PubMed ID: 11127819
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation.
Gardiol D; Kühne C; Glaunsinger B; Lee SS; Javier R; Banks L
Oncogene; 1999 Sep; 18(40):5487-96. PubMed ID: 10523825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]